Avraham Gabay's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 42,000 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,000 | 434,040 (2%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,000 | 392,040 (2%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 188,000 | 358,040 (2%) | 1% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 30,000 | 170,040 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 140,040 | 0 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |